7 Trinity Biotech PTE Ltd – Trademark Portfolio
Entity Type: 99
7 Trinity Biotech PTE Ltd holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include HR HEALTH. The owner is based in Singapore.
80 Robinson Road, #14-02
Singapore 068898 , SG
Showing of trademarks Trademarks
Trademark Classifications
7 Trinity Biotech PTE Ltd's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does 7 Trinity Biotech PTE Ltd have?
7 Trinity Biotech PTE Ltd has 7 U.S. trademarks filed with the USPTO. Of these, 1 registered, 6 abandoned.
What trademark classes does 7 Trinity Biotech PTE Ltd file in?
7 Trinity Biotech PTE Ltd files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are 7 Trinity Biotech PTE Ltd's most well-known trademarks?
7 Trinity Biotech PTE Ltd's registered trademark portfolio includes well-known marks such as HR HEALTH. These are among 1 currently registered trademark in the portfolio.
What is 7 Trinity Biotech PTE Ltd's trademark registration success rate?
7 Trinity Biotech PTE Ltd has a 14% trademark registration rate, with 1 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.